Xarelto Lawsuit Cases In MDL Move Forward As Trial Dates Are Announced

June 27, 2016 – – TheProductLawyers.com reports on the latest developments in the cases against Xarelto. Last year, the U.S. Judicial Panel on Multidistrict Litigation consolidated the more than 2,000 cases related to the drug in order to expedite legal proceedings. Multidistrict litigation (MDL) number 2592, which is the result of the consolidation, will be tried in the Eastern District of Louisiana under the supervision of Judge Eldon Fallon.

Four bellwether hearings are expected to begin early in 2017. These proceedings will test the reaction of jurors to informational and evidentiary presentations, and will be used for future trials related to the MDL. The first two bellwether cases will be tried in the Eastern District of Louisiana on February 6th and March 13th of next year. However, the other two cases will be tried elsewhere on April 24th and May 30th of 2017.

While it was initially hailed as a breakthrough in the treatment of dangerous blood clots, the new-generation anticoagulant has since caused great concern for the public. As the litigation against Xarelto and its manufacturers has accumulated in recent years, a few major trends have emerged. Plaintiffs allege that use of the drug places patients at a heightened risk of catastrophic bleeding episodes, often adding the claim that the manufacturers were negligent in their duty to inform both physicians and patients of this risk.

The combined number of cases brought against Xarelto in the United States alone stands to exceed 4,000, many of which claim substantial harm as a result of using Xarelto or allege negligence on the part of the drug companies, Bayer AG, and Janssen Pharmaceuticals. Plaintiffs are confident that as the date for the bellwether trials approaches, additional independent claims will be added to the MDL. In Philadelphia, Pennsylvania, a mass tort program composed of 550 individual cases has been consolidated by the Court of Common Pleas.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60011026